Hematological Cancer News

Get the latest cancer news and research. Sort by cancer type or read the current headlines to learn what’s happening in the science of cancer detection and treatment, as well as healthy living tips for dealing with cancer.

Nov

18

Synta Presents Preclinical Data On Next Generation Hsp90 Inhibitor, STA-9090

Synta Pharmaceuticals Corp, a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models.

Nov

17

Cancer Survivor Ready for Next Challenge: Off-Road Racing’s Baja 1000

Joe Bacal survived Hodgkin's lymphoma and now he takes on the Baja 1000 - a 675-mile off-road race through the Mexican desert. Bacal hopes to inspire other cancer patients to take control of their cancer care.

Nov

16

Lifestyle Could Reduce Cancer Two-Thirds

U.S. health experts say about two-thirds of cancers could be prevented via lifestyle changes. The Mayo Clinic researchers explain in their Special Report on Cancer Prevention in the November issue of Mayo Clinic Women's HealthSource says maintaining proper weight by eating a healthy, low-fat diet and by stepping up moderate to vigorous physical activity to 45 to 60 minutes almost daily might reduce one- third of cancer deaths.

Nov

16

Medical Patients Drawn To Internet When Managing Own Health

When the pain in her knee from an old running injury continued even after surgery, Sarah McCluan turned to the Internet for help. I don't use it to diagnose ,but I do go to the Internet for basic information," said McCluan, who downloaded some knee strengthening exercises that she is following. McCluan, 37, of Hopewell is among a growing number of wired adults searching the Internet for medical information.

Nov

12

Study Shows MabThera Maintenance Treatment Delays Disease Progression In Patients With Incurable Lymphoma

Roche announced results from the international phase III study PRIMA1, which show that MabThera (rituximab) maintenance therapy can significantly increase the time until the disease progresses in newly-treated patients with advanced follicular lymphoma, a common and slow-developing but incurable form of lymphoma.

Nov

12

Research On Brain Metastasis Detailed By Scientists At University Of Pittsburgh

According to recent research from the United States, Radiosurgery for brain metastasis fails in some patients, who require further surgical care. In this paper the authors' goal was to evaluate prognostic factors that correlate with the survival of patients who require a resection of a brain metastasis after stereotactic radiosurgery (SRS).

Nov

12

Studies From Northwestern University, Medical Department Yield New Data On Myeloma

Multiple myeloma, an incurable plasma cell malignancy, is characterized by altered cellular metabolism and resistance to apoptosis. Recent connections between glucose metabolism and resistance to apoptosis provide a compelling rationale for targeting metabolic changes in cancer, scientists in the United States report.

Nov

12

Researchers From Harvard University Report Recent Findings In Cancer

Several components of the Writ signaling cascade have been shown to function either as tumor suppressor proteins or as oncogenes in multiple human cancers, underscoring the relevance of this pathway in oncogenesis and the need for further investigation of Wnt signaling components as potential targets for cancer therapy.

Nov

10

NCCN Receives Research Grant To Evaluate Pralatrexate In Solid Tumors And Hematologic Malignancies

NCCN recently received a research grant from Allos Therapeutics, Inc. to evaluate the role of pralatrexate in the treatment of select hematologic malignancies and solid tumors. Pralatrexate is the only agent currently approved by the FDA to treat patients with relapsed or refractory peripheral T-cell lymphoma. Investigators from NCCN Member Institutions are eligible to apply for the research funding.

Nov

09

Study Offers More Evidence To Green Tea's Anti-Cancer Effect

A new U.S. study has shown that green tea may help reduce the risk of oral cancer, although scientists are reluctant to officially endorse green tea as an effective way of cancer prevention.

Page(s): 1 2 3 4 5 6 7 ...155156 Next 

We care about your feedback. Let us know how we can improve your CancerCompass experience.